271 related articles for article (PubMed ID: 24608801)
1. RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma.
Bish R; Vogel C
Mol Cells; 2014 May; 37(5):357-64. PubMed ID: 24608801
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma-associated mutations in the DEAD-box RNA helicase DDX3X/DED1 cause specific defects in translation.
Brown NP; Vergara AM; Whelan AB; Guerra P; Bolger TA
J Biol Chem; 2021; 296():100296. PubMed ID: 33460649
[TBL] [Abstract][Full Text] [Related]
3. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
[TBL] [Abstract][Full Text] [Related]
4. The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract][Full Text] [Related]
5. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis.
Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO
Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated mutants of RNA helicase DDX3X are defective in RNA-stimulated ATP hydrolysis.
Epling LB; Grace CR; Lowe BR; Partridge JF; Enemark EJ
J Mol Biol; 2015 May; 427(9):1779-1796. PubMed ID: 25724843
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.
Oh S; Flynn RA; Floor SN; Purzner J; Martin L; Do BT; Schubert S; Vaka D; Morrissy S; Li Y; Kool M; Hovestadt V; Jones DT; Northcott PA; Risch T; Warnatz HJ; Yaspo ML; Adams CM; Leib RD; Breese M; Marra MA; Malkin D; Lichter P; Doudna JA; Pfister SM; Taylor MD; Chang HY; Cho YJ
Oncotarget; 2016 May; 7(19):28169-82. PubMed ID: 27058758
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed TP73 induces apoptosis in medulloblastoma.
Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
[TBL] [Abstract][Full Text] [Related]
12. PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma.
Burger MC; Brucker DP; Baumgarten P; Ronellenfitsch MW; Wanka C; Hasselblatt M; Eccles MR; Klingebiel T; Weller M; Rieger J; Mittelbronn M; Steinbach JP
Int J Oncol; 2012 Jul; 41(1):235-41. PubMed ID: 22552444
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation.
Valentin-Vega YA; Wang YD; Parker M; Patmore DM; Kanagaraj A; Moore J; Rusch M; Finkelstein D; Ellison DW; Gilbertson RJ; Zhang J; Kim HJ; Taylor JP
Sci Rep; 2016 May; 6():25996. PubMed ID: 27180681
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
Shi X; Wang Q; Gu J; Xuan Z; Wu JI
Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
[TBL] [Abstract][Full Text] [Related]
15. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
16. YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA.
Kloetgen A; Duggimpudi S; Schuschel K; Hezaveh K; Picard D; Schaal H; Remke M; Klusmann JH; Borkhardt A; McHardy AC; Hoell JI
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585856
[TBL] [Abstract][Full Text] [Related]
17. A CK1 FRET biosensor reveals that DDX3X is an essential activator of CK1ε.
Dolde C; Bischof J; Grüter S; Montada A; Halekotte J; Peifer C; Kalbacher H; Baumann U; Knippschild U; Suter B
J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29222110
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma.
Venkataraman S; Birks DK; Balakrishnan I; Alimova I; Harris PS; Patel PR; Handler MH; Dubuc A; Taylor MD; Foreman NK; Vibhakar R
J Biol Chem; 2013 Jan; 288(3):1918-28. PubMed ID: 23212916
[TBL] [Abstract][Full Text] [Related]
19. DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma.
Patmore DM; Jassim A; Nathan E; Gilbertson RJ; Tahan D; Hoffmann N; Tong Y; Smith KS; Kanneganti TD; Suzuki H; Taylor MD; Northcott P; Gilbertson RJ
Dev Cell; 2020 Aug; 54(4):455-470.e5. PubMed ID: 32553121
[TBL] [Abstract][Full Text] [Related]
20. The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
Andolfo I; Liguori L; De Antonellis P; Cusanelli E; Marinaro F; Pistollato F; Garzia L; De Vita G; Petrosino G; Accordi B; Migliorati R; Basso G; Iolascon A; Cinalli G; Zollo M
Neuro Oncol; 2012 May; 14(5):596-612. PubMed ID: 22411914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]